Los Angeles, CA, United States of America

Sarah Hamm-Alvarez

This inventor holds 7 USPTO granted patents and 6 published patent applications. Top assignee: University of Southern California. Active years: 2017-2025.

USPTO Granted Patents = 7 

% Patents Active = 57.1

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Los Angeles, CA (US) (2017 - 2022)
  • Pasadena, CA (US) (2022)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Sarah Hamm-Alvarez

Introduction

Sarah Hamm-Alvarez is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of biotechnology, particularly in the development of novel protein polymers. With a total of 7 patents, her work has garnered attention for its innovative approaches to drug delivery systems.

Latest Patents

One of her latest patents involves multimeric elastin-like polypeptides. This disclosure provides novel compositions and methods to deliver cyclosporine A using genetically engineered protein polymers. This advancement has the potential to enhance therapeutic efficacy and improve patient outcomes.

Career Highlights

Sarah is affiliated with the University of Southern California, where she continues to push the boundaries of scientific research. Her work not only contributes to academic knowledge but also has practical applications in medicine and biotechnology.

Collaborations

She has collaborated with notable colleagues, including John Andrew Mackay and Mihir Shah, to further her research initiatives. These partnerships have enriched her work and expanded the impact of her inventions.

Conclusion

Sarah Hamm-Alvarez exemplifies the spirit of innovation in biotechnology through her groundbreaking patents and collaborative efforts. Her contributions are paving the way for advancements in drug delivery systems and improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…